心脏磁共振在肥厚型心肌病诊治中的应用进展  

Cardiac Magnetic Resonance Imaging in Diagnosis and Clinical Management of Hypertrophic Cardiomyopathy

作　　者：崔辰[1] 赵世华[1] 陆敏杰[1,2] CUI Chen;ZHAO Shihua;LU Minjie(Department of Magnetic Resonance Imaging,Fuwai Hospital,National Center for Cardiovascular Diseases,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100037,China;Key Laboratory of Cardiovascular Imaging,Chinese Academy of Medical Sciences,Beijing 100037,China)

机构地区：[1]中国医学科学院北京协和医学院国家心血管病中心阜外医院磁共振影像科,北京100037 [2]中国医学科学院心血管影像重点实验室,北京100037

出　　处：《心血管病学进展》2024年第2期97-102,共6页Advances in Cardiovascular Diseases

基　　金：中央高水平医院临床科研业务费(2022-GSP-QN-17);北京协和医学院2023年度本科教育教学改革项目(2023zlg1026)。

摘　　要：肥厚型心肌病是最常见的遗传性心脏病,可导致患者发生心源性猝死、心力衰竭等严重心血管事件。因此,准确的诊断与危险分层对于临床诊疗至关重要。心脏磁共振可以无创评估患者的心脏结构、功能以及组织特征,在肥厚型心肌病的鉴别诊断以及预后判断中均可发挥重要价值。包括特征追踪、弥散张量成像以及4D flow在内的磁共振新技术也在临床中得到初步应用,有望在肥厚型心肌病发生发展机制研究以及早期诊断中发挥重要作用。Hypertrophic cardiomyopathy(HCM)is the most common inherited heart disease and is associated with adverse cardiovascular events including sudden cardiac death and heart failure.Therefore,accurate diagnosis and risk stratification are of great importance in the clinical management of HCM.Cardiac magnetic resonance imaging can assess the cardiac structure,function and tissue characteristics,playing a crucial role in differential diagnosis and prognosis evaluation in HCM.New magnetic resonance imaging techniques,including feature tracking,diffusion tensor imaging and 4D flow,hold great promise in the investigation of the development mechanisms and early diagnosis of HCM.

关 键 词：肥厚型心肌病 鉴别诊断 心肌纤维化 预后判断 

分 类 号：R542.2[医药卫生—心血管疾病]